These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38735616)

  • 21. A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis.
    Li C; Wu X; Zhang H; Yang G; Hao M; Sheng S; Sun Y; Long J; Hu C; Sun X; Li L; Zheng J
    Int J Biol Macromol; 2015 Apr; 75():115-20. PubMed ID: 25597429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition Effect of Dictyophora Polysaccharides on Human Hepatocellular Carcinoma Cell Line HCC-LM3.
    Hu T; Zhang K; Pan D; Pan X; Yang H; Xiao J; Shen X; Luo P
    Med Sci Monit; 2020 May; 26():e918870. PubMed ID: 32374722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.
    Deng Q; Li KY; Chen H; Dai JH; Zhai YY; Wang Q; Li N; Wang YP; Han ZG
    Hepatology; 2014 Feb; 59(2):518-30. PubMed ID: 23929653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth.
    Luo T; Zhang SG; Zhu LF; Zhang FX; Li W; Zhao K; Wen XX; Yu M; Zhan YQ; Chen H; Ge CH; Gao HY; Wang L; Yang XM; Li CY
    J Exp Clin Cancer Res; 2019 Mar; 38(1):130. PubMed ID: 30885237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases.
    Ren Y; Li S; Song Z; Luo Q; Zhang Y; Wang H
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
    Bagi CM; Gebhard DF; Andresen CJ
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
    Zhang X; Ng HLH; Lu A; Lin C; Zhou L; Lin G; Zhang Y; Yang Z; Zhang H
    Nanomedicine; 2016 May; 12(4):853-869. PubMed ID: 26772424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.
    Pollutri D; Patrizi C; Marinelli S; Giovannini C; Trombetta E; Giannone FA; Baldassarre M; Quarta S; Vandewynckel YP; Vandierendonck A; Van Vlierberghe H; Porretti L; Negrini M; Bolondi L; Gramantieri L; Fornari F
    Cell Death Dis; 2018 Jan; 9(1):4. PubMed ID: 29305580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect.
    Guo C; Hou X; Liu Y; Zhang Y; Xu H; Zhao F; Chen D
    Phytomedicine; 2021 Jan; 80():153356. PubMed ID: 33039729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burning down the house: Pyroptosis in the tumor microenvironment of hepatocellular carcinoma.
    Cheng C; Hsu SK; Chen YC; Liu W; Shu ED; Chien CM; Chiu CC; Chang WT
    Life Sci; 2024 Jun; 347():122627. PubMed ID: 38614301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapeutic targets and predictive markers for hepatocellular carcinoma.
    Chan SL; Chan AW; Yeo W
    Expert Opin Ther Targets; 2015 Jul; 19(7):973-83. PubMed ID: 25910512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma.
    Gong J; Chuang J; Cho M; Toomey K; Hendifar A; Li D
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Therapy for Hepatocellular Carcinoma.
    Ohri N; Kaubisch A; Garg M; Guha C
    Semin Radiat Oncol; 2016 Oct; 26(4):338-43. PubMed ID: 27619254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging drugs for the treatment of hepatocellular carcinoma.
    Ayoub WS; Jones PD; Yang JD; Martin P
    Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Gekko sulfated polysaccharide-protein complex on human hepatoma SMMC-7721 cells: inhibition of proliferation and migration.
    Chen D; Yao WJ; Zhang XL; Han XQ; Qu XY; Ka WB; Sun DG; Wu XZ; Wen ZY
    J Ethnopharmacol; 2010 Feb; 127(3):702-8. PubMed ID: 19969061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the Autophagy-lysosomal Pathway in Hepatocellular Carcinoma Using Small Molecules.
    Lee YG; Jeon TI
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
    Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
    Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
    Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.